QSC Tirzepatide is a novel peptide compound acting as a triple agonist of glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). This pharmaceutical grade compound is supplied as a white powder with purity exceeding 99.9%.
The molecular sequence of QSC Tirzepatide is: H-Tyr Aib Glu Gly Thr He Thr Ser Ile Aib Eu Asp Lys Ile Ala Gln (AEEA) 2-Lys} - Ala He Gal Trp Leu Ala Gly Gly Ser Gly Ala Pro Pro Ser NH2. This unique structure contributes to its potent biological activity.
Research indicates QSC Tirzepatide shows promising results in studies related to metabolic disorders. Clinical data suggests potential applications in weight management and glucose regulation. The compound has demonstrated significant effects in reducing liver fat content and improving biomarkers associated with metabolic conditions.
For research purposes, QSC Tirzepatide should be stored at -20°C in powder form (stable for 3 years) or -80°C when in solution (stable for 1 year). Proper handling and storage are essential to maintain compound integrity.
Our manufacturing facility maintains strict quality control standards, with each batch accompanied by comprehensive analytical documentation including COA and HPLC reports. We offer flexible packaging options to meet various research requirements.
Note: This product is for research use only. Not for human consumption.